Skip to main navigation Skip to search Skip to main content

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

  • Luis Felipe Reyes Velasco (Another Number Author)
  • , Matthew T Laurie (Another Number Author)
  • , Jamin Liu (Another Number Author)
  • , Sara Vazquez (Another Number Author)
  • , Paul Bastard (First Author)
  • california universit
  • uc san francis
  • laboratory of human genetics of infectious diseases, necker branch, inserm u1163, necker hospital for sick children, paris, fra

Research output: Contribution to journalArticlepeer-review

62 Scopus citations
Original languageEnglish
Pages (from-to)1-18
Number of pages17
JournalScience Inmunology
DOIs
StatePublished - 14 Jun 2022

Article Classification

  • Full research article

Indexación Internacional (Artículo)

  • ISI Y SCOPUS

Scopus-Q Quartil

  • Q1

ISI- Q Quartil

  • Q1

Categoría Publindex

  • A1

Fingerprint

Dive into the research topics of 'Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs'. Together they form a unique fingerprint.

Cite this